Visiopharm
PrivateLast Round
VC Round
Sep 1, 2020
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Visiopharm is a decision/risk analysis company that provides AI-driven precision pathology software for research and diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Visiopharm Comparables
Compare Visiopharm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Deciphex | 87% | |
| Indica Labs | 85% | |
| Aiforia | 82% |
Visiopharm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 1, 2020 | ||||
| VC Round | Aug 24, 2018 | ||||
| Private Equity | Oct 5, 2007 |
Key People
Founding team and executive leadership
Visiopharm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BankInvest | VC Round |
| Northcap Partners | VC Round, Private Equity |
| The Export and Investment Fund of Denmark | VC Round |
| ATP | VC Round |
| C.L. Davids Fond og Samling | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 61% MoM.
- Nov 8, 2025
Monthly visitors increased 106% MoM, reaching 9K.
Visiopharm Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Visiopharm's valuation, stock price, and market status.
Is Visiopharm a public or private company?
Visiopharm is a private company.
What is the current stock price of Visiopharm?
Visiopharm is a private company with no public stock price. No recent secondary market data is available.
How much is Visiopharm worth (valuation)?
Valuation information for Visiopharm is not publicly available.
Can I buy Visiopharm stock?
Visiopharm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Visiopharm's last funding round?
Visiopharm's most recent funding round was VC Round on September 1, 2020.
Who are the main investors in Visiopharm?
Key investors in Visiopharm include BankInvest, Northcap Partners, ATP.
Will Visiopharm IPO soon?
No public IPO plans have been announced for Visiopharm.
How can I track Visiopharm secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Visiopharm's secondary market activity and sign up for updates.